Published in J Natl Cancer Inst on April 01, 1972
Permeability control in animal cells by polyenes: a possibility. Antimicrob Agents Chemother (1973) 1.21
Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents. Br J Cancer (1981) 0.81
Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells. Br J Cancer (1987) 0.75
Cytotoxicity of etretinate and vindesine. Br J Cancer (1985) 0.75
Proceedings: Accentuation of chlorambucil effect by various additives on rat tumour cells in culture. Br J Cancer (1974) 0.75
Trial of an aromatic retinoid in patients with solid tumours. Br J Cancer (1982) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03
Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
Electromagnetic midsagittal articulometer systems for transducing speech articulatory movements. J Acoust Soc Am (1992) 3.31
Adult intussusception; case report of recurrent intussusception and review of the literature. Am J Surg (1976) 3.27
Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol (2001) 2.57
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Informed consent in complementary and alternative medicine. Arch Intern Med (2001) 2.11
Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet (1982) 2.02
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88
Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83
Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas. Cancer Treat Rep (1979) 1.82
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79
Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
A phase-shift model for the spatial and temporal organization of developing systems. J Theor Biol (1969) 1.67
Control of Aggregation in Dictyostelium discoideum by an External Periodic Pulse of Cyclic Adenosine Monophosphate. Science (1972) 1.65
Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62
Adult Wilms tumor: a report of prolonged survival and review of literature. J Urol (1980) 1.62
Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy. J Natl Cancer Inst (1981) 1.59
Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58
CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer (1979) 1.57
Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis (2001) 1.53
Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50
Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology (2009) 1.47
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS (2001) 1.45
What do you do when the blood pressure is up? An approach to the known hypertensive who has an elevated blood pressure. J Gen Intern Med (1991) 1.44
Smoking abstinence and small cell lung cancer survival. An association. JAMA (1980) 1.43
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Cavernous haemangioma of the retina and optic disc. A report of three cases and a review of the literature. Br J Ophthalmol (1975) 1.42
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Wave propagation in the early stages of aggregation of cellular slime molds. J Theor Biol (1971) 1.35
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep (1979) 1.35
Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34
Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. Cancer Chemother Rep (1972) 1.32
Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med (1987) 1.30
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep (1977) 1.29
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care (2006) 1.28
In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26
Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer (1971) 1.25
Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med (1967) 1.25
Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis (1981) 1.24
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery (1978) 1.23
Advances in small cell bronchogenic carcinoma. Cancer Treat Rep (1977) 1.23
Control of developing fields. Annu Rev Biophys Bioeng (1972) 1.23
A pilot study of cancer knowledge and screening behaviors of Vietnamese and Cambodian women. Health Care Women Int (1999) 1.18
Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile. Cancer (1975) 1.17
Treatment of bronchogenic carcinoma. II. Small cell. Cancer Treat Rev (1977) 1.16
Central nervous system involvement in Burkitt's lymphoma. Blood (1970) 1.16
Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res (1968) 1.16
The health consequences of smoking. Cancer. Med Clin North Am (1992) 1.15
Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer (1983) 1.14
Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood (1971) 1.14
Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? No. Cancer Treat Rep (1983) 1.13
Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland. Eur J Cancer (1978) 1.13
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer (1978) 1.13
Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer. Am J Med (1986) 1.13
Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin. Am J Med (1987) 1.13
Chemotaxis and the early stages of aggregation in cellular slime molds. J Theor Biol (1971) 1.12
The carcinomatous neuromyopathy of oat cell lung cancer. Ann Neurol (1980) 1.12
A lesson from the mammography issue. Ann Intern Med (1978) 1.11
Immunological studies in tropical splenomegaly syndrome in Uganda. Br Med J (1969) 1.11
The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer (1982) 1.11
Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine. J Natl Cancer Inst (1972) 1.11
Lymphoma of the breast. Ann Surg (1981) 1.11
Pneumocystis carinii pneumonia. Ann Intern Med (1968) 1.10
Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med (1980) 1.09
Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst (1975) 1.09
Altered taste thresholds in lung cancer. Am J Clin Nutr (1978) 1.08
Small cell bronchogenic carcinoma: a distinct clinicopathologic entity. Semin Oncol (1978) 1.08
Development of infundibular obstruction after percutaneous pulmonary balloon valvuloplasty. J Am Coll Cardiol (1985) 1.08
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. Cancer Res (1965) 1.08
Acetohydroxamate: bacterial urease inhibitor with therapeutic potential in hyperammonaemic states. Nature (1965) 1.07
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.07
Pyeloduodenal fistula: report of a case and review of the literature. J Urol (1966) 1.04
Serum immune globulin concentrations in acute leukemia during intensive chemotherapy. Cancer (1965) 1.03
Inhibition of the growth and development of a transplantable murine melanoma by vitamin A. Science (1975) 1.02
Bacteremia due to gram-positive cocci in patients with neoplastic disease. Am J Med (1979) 1.02
Staging laparotomy in the treatment of metastatic melanoma of the lower extremities. Ann Surg (1975) 1.01
Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep (1981) 1.01
Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy. JAMA (1976) 1.01
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol (1990) 1.01
The Philadelphia chromosome and chronic myelogenous leukemia. J Natl Cancer Inst (1966) 1.00
Neoplasms of the large bowel following ureterosigmoidostomy. Arch Surg (1977) 0.99